These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8723485)

  • 1. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
    Korba BE; Boyd MR
    Antimicrob Agents Chemother; 1996 May; 40(5):1282-4. PubMed ID: 8723485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir.
    Shaw T; Mok SS; Locarnini SA
    Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
    Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent.
    Zembower DE; Lin YM; Flavin MT; Chen FC; Korba BE
    Antiviral Res; 1998 Aug; 39(2):81-8. PubMed ID: 9806485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the replication of the DNA polymerase M550V mutation variant of human hepatitis B virus by adefovir, tenofovir, L-FMAU, DAPD, penciclovir and lobucavir.
    Ying C; De Clercq E; Nicholson W; Furman P; Neyts J
    J Viral Hepat; 2000 Mar; 7(2):161-5. PubMed ID: 10760047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of novel human hepatoma cell lines with stable hepatitis B virus secretion for evaluating new compounds against lamivudine- and penciclovir-resistant virus.
    Fu L; Cheng YC
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3402-7. PubMed ID: 11083647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of L-(-)2,3-dideoxythiacytidine resistant hepatitis B virus to other antiviral nucleoside analogues.
    Fu L; Liu SH; Cheng YC
    Biochem Pharmacol; 1999 Jun; 57(12):1351-9. PubMed ID: 10353255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC).
    Das K; Xiong X; Yang H; Westland CE; Gibbs CS; Sarafianos SG; Arnold E
    J Virol; 2001 May; 75(10):4771-9. PubMed ID: 11312349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of combination therapies against hepatitis B virus replication.
    Korba BE
    Antiviral Res; 1996 Jan; 29(1):49-51. PubMed ID: 8721544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
    Périgaud C; Gosselin G; Girardet JL; Korba BE; Imbach JL
    Antiviral Res; 1999 Jan; 40(3):167-78. PubMed ID: 10027651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.
    Lada O; Benhamou Y; Cahour A; Katlama C; Poynard T; Thibault V
    Antivir Ther; 2004 Jun; 9(3):353-63. PubMed ID: 15259898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine.
    King RW; Ladner SK; Miller TJ; Zaifert K; Perni RB; Conway SC; Otto MJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3179-86. PubMed ID: 9835512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin and mycophenolic acid potentiate the activity of guanine- and diaminopurine-based nucleoside analogues against hepatitis B virus.
    Ying C; De Clercq E; Neyts J
    Antiviral Res; 2000 Nov; 48(2):117-24. PubMed ID: 11114413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro system for screening anti-hepatitis B virus drugs.
    Ueda K; Tsurimoto T; Nagahata T; Chisaka O; Matsubara K
    Virology; 1989 Mar; 169(1):213-6. PubMed ID: 2466368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.
    Shaw T; Amor P; Civitico G; Boyd M; Locarnini S
    Antimicrob Agents Chemother; 1994 Apr; 38(4):719-23. PubMed ID: 8031035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anti-hepatitis B virus effects of lamivudine and other five drugs in vitro].
    Cao H; Tao P
    Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(16):1004-7. PubMed ID: 11718074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ring-expanded nucleoside analogs exhibit potent and selective inhibition of hepatitis B virus replication in cultured human hepatoblastoma cells.
    Sood RK; Bhadti VS; Fattom AI; Naso RB; Korba BE; Kern ER; Chen HM; Hosmane RS
    Antiviral Res; 2002 Feb; 53(2):159-64. PubMed ID: 11750942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of the anti-hepatitis B virus activity and cross-resistance profile of 2',3'-dideoxy-3'-fluoroguanosine.
    Jacquard AC; Brunelle MN; Pichoud C; Durantel D; Carrouée-Durantel S; Trepo C; Zoulim F
    Antimicrob Agents Chemother; 2006 Mar; 50(3):955-61. PubMed ID: 16495257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
    Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine, adefovir and tenofovir exhibit long-lasting anti-hepatitis B virus activity in cell culture.
    Ying C; De Clercq E; Neyts J
    J Viral Hepat; 2000 Jan; 7(1):79-83. PubMed ID: 10718947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.